Evidence map›Paper›PMID 42277789›Full record

ArticleBMC complementary medicine and therapies2026

Ameliorative effect of Annona muricata seed extract on testosterone-induced benign prostatic hyperplasia in rats: biochemical, histopathological, and in silico evidence of 5-alpha reductase inhibition.

Juliet Nwamaka Ozioko-Agbo, Daniel Emmanuel Ekpo, Christian Chijioke Amah, Michael Chinedu Chukwu, Parker Elijah Joshua, Lawrence Uchenna Sunday Ezeanyika

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juliet Nwamaka Ozioko-Agbo *Biochemistry Unit, Department of Science Laboratory Technology, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria.ORCID http://orcid.org/0000-0002-9548-1382
Daniel Emmanuel Ekpo *Department of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria. ekpodaniele@gmail.com.ORCID http://orcid.org/0000-0001-9201-8811
Christian Chijioke AmahDepartment of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria.ORCID http://orcid.org/0000-0002-1313-0408
Michael Chinedu ChukwuDepartment of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria.ORCID http://orcid.org/0009-0002-1928-7956
Parker Elijah JoshuaDepartment of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria. Parker.joshua@unn.edu.ng.ORCID http://orcid.org/0000-0002-1837-0312
Lawrence Uchenna Sunday EzeanyikaDepartment of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka, Enugu State, 410001, Nigeria.ORCID http://orcid.org/0000-0002-3124-066X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnnona muricata L., known for its medicinal properties, has been explored for its potential in treating benign prostatic hyperplasia (BPH). While previous studies have noted its numerous health benefits, this research evaluated the therapeutic potential of seed extract of Annona muricata (SEAM) against BPH in rats by exploring in vivo and in silico approaches.

methodsSEAM extraction, phytochemical analysis, in vitro antioxidant activities, and acute toxicity were achieved using standard methods. Thirty male Wistar rats (weight: 158-192 g) were randomly divided into six groups of five rats each. The groups were assigned as follows: (1) normal control, (2) negative control, (3) positive control, and (4-6) experimental groups. BPH was induced in rats of groups (2-6) by subcutaneous injection of 3 mg/kg body weight (b.w) testosterone for 28 days, followed by daily oral treatment with 5 mg/kg b.w. Finasteride, 200, 400 and 600 mg/kg b.w SEAM, respectively for 21 days. The effect of SEAM treatment on changes in rats' biochemical, hematological, and histological indices was assessed.

resultsExtraction of 3000 g of A. muricata seeds yielded 255.6 g SEAM. GC-MS analysis of SEAM revealed flavonoids, alkaloids, polyphenols, and saponins. SEAM exhibited strong radical scavenging activity in vitro. BPH induction in rats triggered significant (p < 0.05) alterations in some biochemical, hematological and histological profiles of test rats. Notably, SEAM significantly (p <0.05) normalized altered levels of prostate-specific antigen, testosterone, antioxidant enzymes, and hematological parameters of treated rats, and is comparable to the standard drug, Finasteride. Molecular docking studies revealed strong binding interactions between SEAM phytochemicals and 5-alpha reductase, suggesting inhibition of this enzyme as a key mechanism of SEAM action.

conclusionsOur study not only confirms the therapeutic potential of SEAM in BPH management but also provides insights into novel biochemical pathways and molecular interactions. These findings indicate that SEAM possess significant anti-BPH property through antioxidant activity and 5-alpha reductase inhibitory activity, providing scientific validation for its potential as a natural remedy for BPH, and setting the stage for further mechanistic studies and clinical trials.

Indexed as

5-alpha Reductase InhibitorsAnnonaPlant ExtractsProstatic HyperplasiaAnimalsAntioxidantsMaleRatsRats, WistarSeedsTestosterone5-alpha Reductase InhibitorsAntioxidantsPlant ExtractsTestosterone5α-reductaseAnnona muricataAntioxidant activityBenign prostatic hyperplasiaPhytotherapy

Identifiers

PMID42277789
PMCPMC13483705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.